Literature DB >> 11404222

Regional physiological adaptation of the central nervous system deiodinases to iodine deficiency.

R Peeters1, C Fekete, C Goncalves, G Legradi, H M Tu, J W Harney, A C Bianco, R M Lechan, P R Larsen.   

Abstract

The goal of the present investigation was to analyze the types 2 (D2) and 3 (D3) iodothyronine deiodinases in various structures within the central nervous system (CNS) in response to iodine deficiency. After 5-6 wk of low-iodine diet (LID) or LID + 2 microg potassium iodide/ml (LID + KI; control), rats' brains were processed for in situ hybridization histochemistry for D2 and D3 mRNA or dissected, frozen in liquid nitrogen, and processed for D2 and D3 activities. LID did not affect weight gain or serum triiodothyronine, but plasma thyroxine (T4) was undetectable. In the LID + KI animals, D3 activities were highest in the cerebral cortex (CO) and hippocampus (HI), followed by the olfactory bulb and was lowest in cerebellum (CE). Iodine deficiency decreased D3 mRNA expression in all CNS regions, and these changes were accompanied by three- to eightfold decreases in D3 activity. In control animals, D2 activity in the medial basal hypothalamus (MBH) was similar to that in pituitary gland. Of the CNS D2-expressing regions analyzed, the two most responsive to iodine deficiency were the CO and HI, in which an approximately 20-fold increase in D2 activity occurred. Other regions, i.e., CE, lateral hypothalamus, MBH, and pituitary gland, showed smaller increases. The distribution of and changes in D2 mRNA were similar to those of D2 activity. Our results indicate that decreases in the expression of D3 and increases in D2 are an integral peripheral component of the physiological response of the CNS to iodine deficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404222     DOI: 10.1152/ajpendo.2001.281.1.E54

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  31 in total

Review 1.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 2.  Multigenic control of thyroid hormone functions in the nervous system.

Authors:  Jacques Nunez; Francesco S Celi; Lily Ng; Douglas Forrest
Journal:  Mol Cell Endocrinol       Date:  2008-03-25       Impact factor: 4.102

Review 3.  Thyroid hormone and cerebellar development.

Authors:  Grant W Anderson
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 4.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

5.  Distribution of hypophysiotropic thyrotropin-releasing hormone (TRH)-synthesizing neurons in the hypothalamic paraventricular nucleus of the mouse.

Authors:  Andrea Kádár; Edith Sánchez; Gábor Wittmann; Praful S Singru; Tamás Füzesi; Alessandro Marsili; P Reed Larsen; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  J Comp Neurol       Date:  2010-10-01       Impact factor: 3.215

Review 6.  Physiological role and regulation of iodothyronine deiodinases: a 2011 update.

Authors:  A Marsili; A M Zavacki; J W Harney; P R Larsen
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

7.  The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients.

Authors:  Yoon Young Cho; Hye Jeong Kim; Hye Won Jang; Tae Hyuk Kim; Chang-Seok Ki; Sun Wook Kim; Jae Hoon Chung
Journal:  Endocrine       Date:  2017-05-02       Impact factor: 3.633

8.  Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.

Authors:  Sungro Jo; Tatiana L Fonseca; Barbara M L C Bocco; Gustavo W Fernandes; Elizabeth A McAninch; Anaysa P Bolin; Rodrigo R Da Conceição; Joao Pedro Werneck-de-Castro; Daniele L Ignacio; Péter Egri; Dorottya Németh; Csaba Fekete; Maria Martha Bernardi; Victoria D Leitch; Naila S Mannan; Katharine F Curry; Natalie C Butterfield; J H Duncan Bassett; Graham R Williams; Balázs Gereben; Miriam O Ribeiro; Antonio C Bianco
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

9.  Type 2 Deiodinase Disruption in Astrocytes Results in Anxiety-Depressive-Like Behavior in Male Mice.

Authors:  Barbara M L C Bocco; João Pedro Werneck-de-Castro; Kelen C Oliveira; Gustavo W Fernandes; Tatiana L Fonseca; Bruna P P Nascimento; Elizabeth A McAninch; Esther Ricci; Zsuzsanna Kvárta-Papp; Csaba Fekete; Maria Martha Bernardi; Balázs Gereben; Antonio C Bianco; Miriam O Ribeiro
Journal:  Endocrinology       Date:  2016-08-08       Impact factor: 4.736

10.  Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase.

Authors:  Lily Ng; Richard J Goodyear; Chad A Woods; Mark J Schneider; Edward Diamond; Guy P Richardson; Matthew W Kelley; Donald L St Germain; Valerie Anne Galton; Douglas Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.